Lynn Seely – Biography
Last update: March 9, 2026Executive profile
Lynn was Director at Blueprint Medicines, and President & Chief Executive Officer at Myovant Sciences. Lynn served as Board Member at Lyell Immunopharma.
Lynn Seely is currentlyDirector, President and Chief Executive Officer at Lyell Immunopharma - View - Lyell Immunopharma org chart
Create your alert
to follow the career of Lynn Seely.
Education
Lynn Seely has a Doctor of Medicine in Internal Medicine from University of Oklahoma.
They have also studied at University of Oklahoma :
Find more alumni from University of Oklahoma
More about Lynn Seely
Selected links
Do you need to know more about Lynn Seely? More results.
Participate
Social media
- Lynn Seely on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Lynn Seely
The colleagues of Lynn Seely
Company Colleagues
- At Lyell Immunopharma, Lynn Seely has 26 colleagues including Mark Bachleda (Director), Catherine Friedman (Director)…
Industry Colleagues
- In the Biotechnology industry, Lynn Seely has 35,756 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Get in Touch
Here are a few tips for establishing great contacts.
